As of 2026-02-18, the Relative Valuation of Spruce Biosciences Inc (SPRB) is (379.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.25 USD, the upside of Spruce Biosciences Inc based on Relative Valuation is -750.7%.
The range of the Relative Valuation is (265.31) - (514.16) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.4x - 15.2x | 10.3x |
| Forward P/E multiples | 7.4x - 14.4x | 10.9x |
| Fair Price | (265.31) - (514.16) | (379.01) |
| Upside | -555.5% - -982.8% | -750.7% |
| Date | P/E |
| 2026-02-17 | -1.63 |
| 2026-02-13 | -1.85 |
| 2026-02-12 | -2.32 |
| 2026-02-11 | -2.31 |
| 2026-02-10 | -2.34 |
| 2026-02-09 | -2.21 |
| 2026-02-06 | -2.02 |
| 2026-02-05 | -1.98 |
| 2026-02-04 | -2.22 |
| 2026-02-03 | -2.34 |
| 2026-02-02 | -2.18 |
| 2026-01-30 | -2.17 |
| 2026-01-29 | -2.23 |
| 2026-01-28 | -2.29 |
| 2026-01-27 | -2.36 |
| 2026-01-26 | -2.31 |
| 2026-01-23 | -2.28 |
| 2026-01-22 | -2.38 |
| 2026-01-21 | -2.21 |
| 2026-01-20 | -2.00 |
| 2026-01-16 | -2.06 |
| 2026-01-15 | -2.09 |
| 2026-01-14 | -2.19 |
| 2026-01-13 | -2.28 |
| 2026-01-12 | -2.18 |
| 2026-01-09 | -2.24 |
| 2026-01-08 | -2.06 |
| 2026-01-07 | -2.18 |
| 2026-01-06 | -2.25 |
| 2026-01-05 | -2.30 |
| 2026-01-02 | -2.54 |
| 2025-12-31 | -2.44 |
| 2025-12-30 | -2.31 |
| 2025-12-29 | -2.30 |
| 2025-12-26 | -2.40 |
| 2025-12-24 | -2.35 |
| 2025-12-23 | -2.34 |
| 2025-12-22 | -2.32 |
| 2025-12-19 | -2.20 |
| 2025-12-18 | -2.15 |
| 2025-12-17 | -2.12 |
| 2025-12-16 | -2.18 |
| 2025-12-15 | -2.26 |
| 2025-12-12 | -2.33 |
| 2025-12-11 | -2.47 |
| 2025-12-10 | -2.40 |
| 2025-12-09 | -2.66 |
| 2025-12-08 | -2.28 |
| 2025-12-05 | -2.24 |
| 2025-12-04 | -2.53 |